Details For Selected Brain Tumor Treatment

Sponsored By

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		High dose erlotinib for recurrent/residual GBM; Correlation of response to EGFRvIII and PTEN status

		Phase:		Phase 1/2

		Treatment ID#:		1834

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		11/08/2007

		Tumor Types:		Any Malignant Brain Tumor Glioblastoma Multiforme


		Comments:

		Treatment Type:		Surgery Chemotherapy

		Contact:		John Boockvar MD Assistant Professor of Neurological Surgery Weill Cornell Medical College 525 E. 68th Street, Box 99 New York, NY 10021 USA Phone: 212-746-1996 Fax: 212-746-8947 E-mail: jab2029@med.cornell.edu Website: www.cornellneurosurgery.org/braintumor

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By